Breaking AI & Tech News Analyzed

Los Angeles residents are facing sticker shock over the presale ticket prices for the 2028 Olympics, with many expressing frustration over the high costs. The tickets, which went on sale for local residents on April 2, range in price from $28 to thousands of dollars.Many residents found that the lower-priced tickets quickly sold out or were unavailable for popular sports like gymnastics and track and field, leaving them with more expensive options. A 24% service fee was also added to the ticket prices, which some residents found excessive.One resident, Kathy Dorn, spent around $1,200 on tickets to watch the rhythmic and artistic gymnastics preliminaries and the sailing finals. She was deterred from buying a ticket to a swimming event due to the high price of $558 per ticket for a two-hour event.Another resident, Tony Anthony, spent $11,000 on eight tickets for track and field events, with nearly $400 going toward the service fee. He noted that the lower-priced tickets were not available during his time slot.The LA Olympics committee has defended the ticket prices, stating that most of the $28 tickets went to purchasers in southern California and Oklahoma City. They also noted that the ticket prices are meant to ensure that the Games can break even without burdening the city with costs.The high ticket prices have raised concerns among residents, particularly in Inglewood, where the opening ceremony and some events will take place. Some residents are worried that they will be priced out of attending the Games and will have to bear the burden of traffic, congestion, and noise during the events.

Scientists at London's Institute of Cancer Research and the RCSI University of Medicine and Health Sciences in Dublin have announced a new AI-driven approach to identify how patients with advanced bowel cancer will respond to bevacizumab, a drug recently introduced by the NHS. The method uses PhenMap, an AI tool that integrates complex data on the genetic makeup of tumors, allowing researchers to track patterns of how different patients react to the drug. This development aims to spare potentially thousands of patients from being given drugs that would be ineffective in fighting their cancers. In the UK alone, nearly 10,000 cases of advanced bowel cancer are identified every year, with young adults seeing a particular rise in diagnoses. Bowel cancer has the second-highest mortality rate of any cancer, behind only lung cancer. While survival rates can be as high as 98% when caught early, the five-year survival rate for advanced bowel cancer can be as low as 10%. The study tracked 117 European bowel cancer patients who had been treated with chemotherapy and bevacizumab. Researchers identified a group of patients who all had the same gene mutation and were at a high risk of having negative reactions. The scientists behind the tests now hope to expand the number of patient samples and see if the results can be used in treatments for other types of cancer. Anguraj Sadanandam, a professor in stratification and precision medicine at the ICR, said: “Once bowel cancer spreads to other parts of the body, there are very few treatment options available for patients. It is therefore positive that patients can now access the targeted drug bevacizumab on the NHS. However, we know that the majority of patients won’t benefit from the drug, meaning thousands of people in England could be facing unpleasant side effects unnecessarily.” Sadanandam added that while the findings were encouraging, the tool would need to be tested on a larger cohort to be validated. “In future, I hope this approach will lead to a test that can be used by clinicians, to ensure patients receive personalised care that has the highest chance of working against their cancer.”

The Pivot from Vision Pro to Everyday WearablesApple is reportedly preparing to enter the smart glasses market with a product launch targeted for 2027, signaling a significant strategic shift away from its ambitious mixed reality ambitions.Four Distinct Design PrototypesRectangular Frames: Ranging from large to slim, potentially mimicking the style of CEO Tim Cook.Oval/Circular Frames: Available in both larger and smaller sizes.Color Options: Black, ocean blue, and light brown.A Strategic Retreat from High-End ARThis move represents a retreat from the complex Vision Pro ecosystem, which faced delays and lukewarm reception. Instead, Apple is betting on a simpler form factor similar to Meta’s Ray-Ban glasses.The 2027 Roadmap: Simplicity Over ImmersionThe upcoming device will lack displays, focusing instead on camera lenses for photos, videos, calls, and music. It will also integrate with the long-promised Siri upgrade, aiming to capture the mainstream market rather than the niche enthusiast base.

Peruvians are heading to the polls to elect their ninth president in less than a decade, a period marked by political instability and corruption scandals that have led to widespread voter disillusionment.Since 2018, Peru has seen eight presidents, with a high turnover rate marred by impeachments and corruption scandals. This has resulted in weak governments and a lack of trust in the political system.On Sunday, 27 million Peruvians are eligible to vote, with polling stations across the country opening at 7am (12:00 GMT) and closing at 5pm (22:00 GMT). Preliminary results are expected shortly afterwards.The presidential ballot features 35 candidates, including a comedian, a media baron, a political dynasty heiress, and a hard-line ex-mayor. However, all major candidates continue to poll well below the 50 percent needed to win the election, making a June 7 run-off appear likely.The most well-known candidate is conservative Keiko Fujimori, who will make her fourth presidential bid. Her candidacy remains polarizing due to her family legacy, with her father, former President Alberto Fujimori, convicted of human rights abuses and corruption.Other notable candidates include Ricardo Belmont, a former mayor of Lima, and Carlos Alvarez, a popular comedian who has campaigned on a platform of being tough on crime. Peru's homicide rate has more than doubled in the past decade, making crime a major concern for voters.Many Peruvians, however, remain disillusioned with the political system and the available candidates. A fruit seller in Lima told the Reuters news agency that she was still undecided on who to vote for, saying "Peru is a mess, and there's no candidate worth voting for." A clothing merchant also shared similar sentiments, stating "We've been governed by nothing but corrupt, thieving scoundrels."

This week Anthropic revealed that its latest AI system, dubbed Mythos, is so powerful that the company will not make it publicly available, arguing that the potential risks outweigh commercial incentives.U.S. Treasury Secretary Scott Bessent convened senior banking executives to discuss the implications of the model, underscoring growing governmental concern over advanced AI capabilities.In the United Kingdom, Reform MP Danny Kruger wrote to the government urging an immediate dialogue with Anthropic, warning that Claude Mythos could pose "catastrophic cybersecurity risks" to the nation.Critics such as AI researcher Gary Marcus questioned the hype, suggesting that Anthropic’s co‑founder Dario Amodei may possess strong technical skills but is "graduated from the same school of hype and exaggeration" as OpenAI’s Sam Altman.Beyond the policy debate, Anthropic has mounted a striking media offensive. The startup secured a 10,000‑word profile in the New Yorker, two feature pieces in the Wall Street Journal, and a Time magazine cover that placed founder Amodei alongside the Pentagon and U.S. Defense Secretary Pete Hegseth.Co‑founder Jack Clark and Amodei appeared on separate New York Times podcasts, fielding questions about machine consciousness and the model’s potential to "rip through the economy." Their "resident philosopher" even discussed with the WSJ whether Claude, Anthropic’s commercial product used for cryptocurrency trading and missile‑target designation, possesses a "sense of self."Anthropic’s public‑relations lead, Danielle Ghiglieri, celebrated the coverage on LinkedIn, describing the Time cover as a "mad dash" that finally let the company tell its own story.However, the company’s PR triumphs have not been without missteps. In early April, Anthropic inadvertently released part of Claude’s internal source code, though it assured that no customer data or credentials were exposed.Experts remain skeptical about the unverified claims surrounding Mythos. Dr. Heidy Khlaaf of the AI Now Institute warned that the vague marketing language could be an attempt to attract investment without substantive scrutiny.Cybersecurity specialist Jameison O’Reilly acknowledged the model’s novelty but downplayed Anthropic’s assertion of discovering "thousands of zero‑day vulnerabilities," noting that in a decade of offensive operations, zero‑days were rarely needed to achieve objectives.Anthropic also faces operational constraints. The firm has imposed usage caps on its popular Claude model and now requires customers to purchase additional compute capacity for third‑party tools, suggesting that infrastructure limitations may be a practical reason for withholding Mythos.As the race to dominate the emerging AI market intensifies, Anthropic’s strategy appears to blend genuine safety concerns with a calculated publicity push, positioning Mythos as a strategic signal that the company remains "open for business" while keeping the technology under tight control.

Match details: Chelsea host Manchester City at Stamford Bridge on Sunday, 12 April, 4:30 pm BST (15:30 GMT). Live coverage and pre‑match analysis will be available on Al Jazeera Sport from 12:30 GMT. City sit second in the Premier League, trailing league leaders Arsenal by nine points after Arsenal played one more game. A win at Chelsea could shrink the gap to six points, and a victory for Arsenal over Bournemouth on Saturday would widen the gap to twelve, putting immense pressure on Pep Guardiola’s side to collect maximum points. Chelsea, currently sixth, are desperate to reignite their push for a top‑five finish that guarantees Champions League football next season. They sit just one point behind Liverpool, who occupy the final European spot. Guardiola warns of zero‑margin for error Speaking on Friday, Pep Guardiola admitted City’s season has been “inconsistent” and stressed that the squad must win every remaining match to retain any chance of clinching the title. He highlighted the demanding run of fixtures ahead, beginning with the Chelsea trip and followed by a home clash with Arsenal on 19 April. “We need to win all of them; otherwise we won’t have a chance to fight until the end,” Guardiola said, acknowledging points dropped earlier in the campaign. Bernardo Silva’s future remains uncertain Midfielder Bernardo Silva, a six‑time Premier League champion with City, is in the final year of his contract. Guardiola expressed a personal desire to keep the Portuguese international at the club but admitted he does not know the player’s decision. “I’m a bit grumpy because I wasn’t informed of his plans,” the manager said, praising Silva’s competitiveness and importance in big‑match moments. Enzo Fernández excluded despite apology Chelsea boss Liam Rosenior confirmed that midfielder Enzo Fernández will remain on the bench for the Sunday fixture, even after the Argentine apologised for comments that questioned his future at Stamford Bridge. Rosenior emphasized the club’s collective values, stating, “Football is a team sport, not about individuals,” and hinted that Fernández could feature again after this match. Chelsea’s Champions League ambition Rosenior reiterated confidence in his squad’s ability to secure a top‑five finish, noting that despite a recent dip in form, the team has consistently created problems for opponents. Historical head‑to‑head The two clubs have met 181 times in competitive fixtures: Chelsea have won 71, City 68, with 42 draws. Notably, Chelsea have not beaten City since the 2021 Champions League final. Recent encounters (last 10): 04 Jan 2026 – Man City 1‑1 Chelsea (Premier League) 25 Jan 2025 – Man City 3‑1 Chelsea (Premier League) 18 Aug 2024 – Chelsea 0‑2 Man City (Premier League) 20 Apr 2024 – Man City 1‑0 Chelsea (FA Cup semi‑final) 17 Feb 2024 – Man City 1‑1 Chelsea (Premier League) 12 Nov 2023 – Chelsea 4‑4 Man City (Premier League) 21 May 2023 – Man City 1‑0 Chelsea (Premier League) 08 Jan 2023 – Man City 4‑0 Chelsea (FA Cup third round) 05 Jan 2023 – Chelsea 0‑1 Man City (Premier League) 09 Nov 2022 – Man City 2‑0 Chelsea (League Cup third round) Team news – Chelsea Rosenior confirmed centre‑back Levi Colwill has returned to training after a serious knee injury, though he remains a selection risk. Right‑back Reece James is training after a hamstring issue. Defender Trevoh Chalobah and winger Jamie Gittens are still sidelined. Predicted starting XI: Sanchez; Gusto, Fofana, Adarabioyo, Cucurella; Santos, Caicedo; Neto, Palmer, Estevao; Pedro. Team news – Manchester City Defender Rúben Dias continues to recover from a muscle problem and is unavailable. Josko Gvardiol remains out with a tibial fracture sustained in January. Predicted starting XI: Donnarumma; Nunes, Khusanov, Guehi, O’Reilly; Silva, Rodri; Semenyo, Cherki, Doku; Haaland. The outcome of this clash could dramatically reshape the Premier League title race and determine whether Chelsea can keep their Champions League aspirations alive.

Barney Ronay set out to test whether a disciplined betting strategy could turn a modest £10 stake into a sizeable profit. Over five days he managed to grow the amount to £120, a return that sounded impressive but left him emotionally flat. His experiment underscores a broader truth: sport betting is engineered to disturb and addict. The personal journey is set against a looming financial shock for English football. Nine Premier League clubs have warned they cannot replace the cash flow previously supplied by gambling sponsors, which will be barred from shirt‑front advertising next season under a voluntary industry agreement. One club executive summed up the anxiety: “Nearly everyone is losing money.” The shortfall is estimated at around £4 million for the affected clubs. These concerns arrive at a time when the gambling sector itself faces scrutiny. Recent data show that up to 1.4 million UK adults may have a gambling problem, a figure that has risen alongside the proliferation of mobile betting apps. The Guardian previously reported that the world‑champion club could incur losses of £335 million in a single season, illustrating the massive financial stakes involved. Ronay’s betting log reads like a sports‑fan’s diary. He began with a £10 wager on a Florida horse race, which paid out modestly. Subsequent bets on high‑profile matches – Manchester City versus Liverpool, Southampton beating Arsenal in the FA Cup – produced a rapid climb to £120. Yet each win felt hollow, prompting him to chase larger, riskier bets such as a four‑way accumulator on the Champions League semi‑finalists, a gamble that ultimately fell short. Beyond the numbers, the piece highlights how gambling permeates the football experience: logos dominate club kits, betting terminology infiltrates fan conversation, and promotional offers tempt even casual viewers. Ronay argues that this saturation turns a simple pastime into a “highly available, stimulating activity designed to hook” users, exploiting the brain’s natural reward pathways. In concluding, Ronay stresses two take‑aways. First, the industry’s promise of “extra money” for clubs is a façade – the money only comes out of fans’ pockets. Second, the impending £4 million sponsorship gap may actually serve as a catalyst for sensible self‑regulation, forcing clubs to reconsider reliance on gambling revenue.

The 2026 Grand National is underway at Aintree, with a sellout crowd gathering to witness one of the most historic and compelling spectacles in sport. A total of 34 runners and riders are set to line up for the big race at 4pm BST. An early smattering of rain is clearing away, with a brighter forecast expected for later in the afternoon. The betting market for the National is already heating up, with an early gamble on Jagwar, one of just three seven-year-olds in the field. Panic Attack, the only mare in the field, is also popular and has taken over at the top of the market at 8-1. Meanwhile, I Am Maximus, yesterday's favourite, has drifted out to 9-1 in a place. Jagwar is top-priced at 17-2. Other notable horses include Oscars Brother from the two-horse yard of Connor King in Ireland; Haiti Couleurs, bidding to be the first Welsh-trained winner since 1905; and Mr Vango, trained by Sara Bradstock. Every punter will have their own strategy for picking a winner. Gorgeous Tom may be a popular choice later, with a decent each-way chance. A full guide to all the runners can be found here, and previews are available here.

American Classic is a heartwarming comedy that celebrates the power of art and human connection. The show follows Richard Bean, played by Kevin Kline, a former theatre star who returns to his small hometown of Millersburg after his mother's death. Richard's journey is filled with humor, wit, and tenderness, as he helps restore the local theatre's fortunes and comes to terms with his past.The show features a talented ensemble cast, including Laura Linney as Kristen, Richard's sister-in-law and the mayor of Millersburg. The series explores themes of grief, love, and the importance of community, making it a delightful watch. American Classic is now available on MGM+ and consists of eight episodes.The show's combination of charm, wit, and tenderness is reminiscent of popular comedies like Ted Lasso and Schitt's Creek. Its retro-tropes and nostalgic feel make it a comforting watch, perfect for audiences looking for a lighthearted and uplifting series.American Classic is a testament to the power of art to bring people together and provide comfort in times of need. The show's authentic belief in the power of art is evident throughout, making it a sweet and moving watch.